Monthly information on share capital and company voting rights

Rhea-AI Summary

Cellectis (CLLS) has released its monthly share capital and voting rights report as of March 31, 2025. The company reported a total of 100,290,078 shares in its capital structure, with 89,046,759 total voting rights. This disclosure complies with Article 223-16 of the General Regulation of the French financial markets authority for companies listed on Euronext Growth.

News Market Reaction

+5.00%

1 alert

+5.00% News Effect

On the day this news was published, CLLS gained 5.00%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, April 07, 2025 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

Date	Total number of shares in the capital	Total number of voting rights
03/31/2025	100,290,078	89,046,759

For further information on Cellectis, please contact:     

Media contacts:       

Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com

Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93

Investor Relations contact:       

Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@cellectis.com

 

Attachment

• Voting_Rights_PR_March_2025_EN

FAQ

What is the total number of Cellectis (CLLS) shares as of March 31, 2025?

Cellectis had 100,290,078 total shares in its capital structure as of March 31, 2025.

How many voting rights does Cellectis (CLLS) have as of March 2025?

Cellectis reported 89,046,759 total voting rights as of March 31, 2025.

What is the difference between Cellectis (CLLS) total shares and voting rights in March 2025?

There is a difference of 11,243,319 between the total shares (100,290,078) and voting rights (89,046,759).

On which exchange is Cellectis (CLLS) stock listed according to the March 2025 report?

Cellectis is listed on Euronext Growth market.